FCMT
CELG

Founders Capital Management (Texas)’s Celgene Corp CELG Stock Holding History

Founders Capital Management (Texas)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-150
Closed -$14K – 339
2019
Q1 		$14K Sell
150
-150
-50% -$13.1K 0.01% 228
2018
Q4 		$19K Hold
300
– – 0.02% 181
2018
Q3 		$27K Hold
300
– – 0.02% 159
2018
Q2 		$24K Hold
300
– – 0.02% 168
2018
Q1 		$27K Hold
300
– – 0.02% 184
2017
Q4 		$31K Buy
300
+50
+20% +$5.64K 0.03% 175
2017
Q3 		$36K Hold
250
– – 0.03% 156
2017
Q2 		$32K Hold
250
– – 0.03% 162
2017
Q1 		$31K Buy
+250
New +$29.9K 0.03% 170

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Founders Capital Management (Texas)'s CELG Position: Q2 2019 in Review

Founders Capital Management (Texas) sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 150 shares — an estimated $14K sold.

Founders Capital Management (Texas) first reported a position in CELG in Q1 2017 and held it in 9 quarters. The position peaked at $36K in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Founders Capital Management (Texas) reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 150 Celgene Corp shares in Q2 2019, an estimated $14K.
  • Founders Capital Management (Texas) first reported a position in Celgene Corp in Q1 2017 and held it in 9 quarters.
  • Founders Capital Management (Texas)'s Celgene Corp position peaked at $36K in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2019, filed 11 Jul 2019.